Detalles de la búsqueda
1.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis
; 78(2): 259-268, 2024 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740559
2.
Exploration of a Potential DOOR Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs.
Clin Infect Dis
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527855
3.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis
; 78(2): 248-258, 2024 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738153
4.
Desirability of outcome ranking for obstetrical trials: illustration and application to the ARRIVE trial.
Am J Obstet Gynecol
; 230(3): 370.e1-370.e12, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741532
5.
The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions.
Clin Infect Dis
; 77(Suppl 4): S279-S287, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843121
6.
Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S288-S294, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843120
7.
Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S314-S320, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843119
8.
The Future Ain't What It Used to Be Out With the Old In With the Better: Antibacterial Resistance Leadership Group Innovations.
Clin Infect Dis
; 77(Suppl 4): S321-S330, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843122
9.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Clin Infect Dis
; 76(3): e1157-e1165, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031403
10.
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S305-S313, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843118
11.
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
Clin Infect Dis
; 77(Suppl 4): S295-S304, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843115
12.
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
N Engl J Med
; 383(3): 207-217, 2020 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668111
13.
Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing.
J Clin Microbiol
; 61(12): e0061423, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962552
14.
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.
Clin Infect Dis
; 73(2): 344-350, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245333
15.
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration.
Clin Infect Dis
; 73(7): 1231-1238, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978146
16.
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Stroke
; 52(11): 3482-3489, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477459
17.
Antibacterial Resistance Leadership Group 2.0: Back to Business.
Clin Infect Dis
; 73(4): 730-739, 2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588438
18.
Presenting Risks and Benefits: Helping the Data Monitoring Committee Do Its Job.
Ann Intern Med
; 172(2): 119-125, 2020 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31739312
19.
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
Clin Infect Dis
; 70(4): 698-703, 2020 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31414121
20.
Average Weighted Accuracy: Pragmatic Analysis for a Rapid Diagnostics in Categorizing Acute Lung Infections (RADICAL) Study.
Clin Infect Dis
; 70(12): 2736-2742, 2020 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157863